(Updated - February 24, 2026 6:49 AM EST)

Wedbush analyst David Nierengarten initiates coverage on Abivax (NASDAQ: ABVX) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE